Singapore markets open in 3 hours 49 minutes

PFE Dec 2025 20.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.7100-0.0300 (-4.05%)
As of 01:36PM EDT. Market open.
Full screen
Previous close0.7400
Open0.7100
Bid0.6300
Ask0.7600
Strike20.00
Expiry date2025-12-19
Day's range0.7100 - 0.7100
Contract rangeN/A
Volume1
Open interest7.89k
  • Benzinga

    European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech

    Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) over the Covid-19 vaccine. The EPO’s Opposition Division upheld the validity of one of Moderna’s crucial patents, boosting the mRNA vaccine maker’s efforts to reclaim pandemic profits from its competitors, the Financial Times reports. Although Pfizer has nine months to appeal the decision, the EPO’s writte

  • Zacks

    Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

    Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

  • Benzinga

    Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game

    On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France, just ahead of this year’s “Choose France” business summit. Together with the domestic Sanofi (NASDAQ: SNY), Pfizer, AstraZeneca will together invest €1.87 billion which is more than $2 billion to expand their operations in the country. AstraZeneca committed 365 million euros, which is about $394 mi